Table 3.
Variable | OR | 95% CI | p-value |
---|---|---|---|
Age | 1.1 | 1.06–1.10 | <0.001 |
Largest tumor size | 0.70 | 0.55–0.88 | 0.002 |
Charlson Comorbidity Index | 1.68 | 1.48–1.91 | <0.001 |
Nephrometry Score | 1.8 | 1.3–2.6 | <0.001 |
(N)earness (1 vs. 3) | 1.9 | 1.1–3.1 | 0.017 |
(N)earness (2 vs. 3) | 1.8 | 0.96–3.3 | 0.050 |
(L)ocation (1 vs. 3) | 1.1 | 0.61–1.9 | 0.002 |
(L)ocation (2 vs. 3) | 0.97 | 0.54–1.7 | 0.922 |
Non-hilar | 2.0 | 0.7–5.9 | 0.192 |
Solitary Kidney | 1.7 | 0.67–4.6 | 0.259 |
Multifocal disease | 2.4 | 1.2–4.9 | 0.016 |
Controlling for gender, race, Eastern Cooperative Oncology Group Score, tumor laterality, endo/exophycity, size, anterior/posterior, and location relative to polar line.